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ABSTRACT
Objectives This study aimed to identify factors
associated with access to HIV care and antiretroviral
(ARV) drugs for prevention of mother-to-child
transmission (PMTCT) of HIV among HIV-positive
pregnant women in a community cohort in rural
Tanzania (Kisesa).
Methods Kisesa-resident women who tested HIV-
positive during HIV serosurveillance and were pregnant
(while HIV-positive) between 2005 and 2012 were
eligible. Community cohort records were linked to
PMTCT and HIV clinic data from four facilities (PMTCT
programme implemented in 2009; referrals to city-based
hospitals since 2005) to ascertain service use. Factors
associated with access to HIV care and ARVs during
pregnancy were analysed using logistic regression.
Results Overall, 24% of women accessed HIV care and
12% accessed ARVs during pregnancy (n=756
pregnancies to 420 women); these proportions increased
over time. In multivariate analyses for 2005–2012, being
married, prior voluntary counselling and testing,
increasing age, increasing year of pregnancy and
increasing duration of infection were independently
associated with access to care and ARVs. Residence in
roadside areas was an independent predictor of access
to care but not ARVs. There was no evidence of an
interaction with time period.
Conclusions Access to PMTCT services was low in this
rural setting but improved markedly over time. There
were fairly few sociodemographic differentials although
support for young women and those without partners
may be needed. Further decentralisation of HIV services
to more remote areas, promotion of voluntary
counselling and testing and implementation of Option
B+ are likely to improve uptake and may bring women
into care and treatment sooner after infection.
BACKGROUND
Services for prevention of mother-to-child trans-
mission (PMTCT) of HIV have been scaled up
rapidly amidst recent commitments to eliminating
vertical transmission, particularly from sub-Saharan
Africa where most paediatric HIV infections
occur.1
PMTCT programmes, through the provision of
antiretroviral (ARV) drugs to HIV-infected mothers
and infants, can substantially reduce the risk of ver-
tical HIV transmission from >40% to <5%.2
However, the availability of this intervention has
not necessarily translated into service uptake.
Coverage with PMTCT ARVs ranged from 13% to
>95% across 21 sub-Saharan African countries in
2012, and reasons for poor uptake are complex, as
barriers exist at multiple levels.1 3 4
Most quantitative studies investigating PMTCT
outcomes are restricted to individuals enrolled in
health services. However, it is important to charac-
terise women who do not access HIV or antenatal
clinics (ANCs) in order to design programmes to
reach all women who need services. Clinic-based
studies are also limited by data available in clinic
records or self-reported in interviews, whereas
unexplored factors such as duration of HIV infec-
tion, previous HIV testing and HIV status of part-
ners, may also predict service use.
Analyses of population-level access to health ser-
vices that link community-level data such as demo-
graphic surveillance systems (DSS) to health facility
records are rarely undertaken. Studies in Malawi
and Kenya reported population-level coverage of
PMTCT or HIV services but did not investigate
factors associated with service use.5 6 Research in an
Ugandan community-based cohort showed that dis-
tance from health services predicted not receiving
an HIV test,7 but did not investigate factors asso-
ciated with receiving ARV drugs. To our knowledge,
no studies have investigated factors associated with
enrolment into PMTCT programmes or uptake of
ARVs among all HIV-positive pregnant women at a
population level, despite the importance for opti-
mising PMTCT programmes. Identifying local bar-
riers to PMTCT uptake is also essential to tailor
programmes to the context. We therefore aim to
identify factors associated with accessing PMTCT
services, including ARV drugs, among HIV-positive
pregnant women in a community cohort in rural
Tanzania.
METHODS
Setting
Kisesa is a rural community in north-western
Tanzania, 20 km east of Mwanza city in Magu dis-
trict. Approximately 30 000 individuals inhabit the
DSS area of roughly 150 km2 that includes a
trading centre and ﬁve other villages (roadside, or
rural, where housing is fairly dispersed). There are
three village dispensaries and a health centre in the
trading centre (government-run). Implementation
of PMTCT services started in 2009, including
provider-initiated HIV testing and counselling and
provision of ARV prophylaxis at ANCs, with
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referrals to the HIV care and treatment clinic (CTC) in the
health centre for long-term care and ARV therapy (ART) (see
ﬁgure 1 and see online supplement 1 for PMTCT protocols).
From 2005 to 2009, pregnant women diagnosed with HIV at
voluntary counselling and testing (VCT) services in the health
centre were referred to hospitals in Mwanza city for PMTCT
services. At the health centre, ANC, CTC and VCT services are
carried out in separate buildings. Antenatal HIV prevalence in
Magu district has declined from 10.7% in 2000 to 8.9% in
2008.8 9
Data collection
The Kisesa cohort study started in 1994,10 with DSS enumer-
ation of the entire population every 6 months. Enumerators visit
households to record all births, pregnancies, migrations and
deaths. HIV serological surveys are conducted approximately
every 3 years (seven to date, most recently in 2013) within each
village among resident adults aged ≥15 years. Participants
consent to give blood for HIV research testing without results
disclosure, are offered VCT, and are interviewed about eco-
nomic activities, childbearing, use of health services, and knowl-
edge of HIV.
Routine clinic data were collected retrospectively from all four
Kisesa facilities (approximately 10% of women in the seventh
serosurvey attended ANC outside Kisesa). All records from 2005
to 2012 were abstracted from ANC pregnancy registers (some
records (<10%) from different clinics and time periods were
missing), PMTCT programme registers and the CTC (including
patients who enrolled at city-based CTCs and transferred back to
Kisesa). Data were double-entered, apart from CTC data.
Community cohort data were linked to clinic data sets by
matching on personal attributes (eg, age, sex, village of resi-
dence and pregnancy dates), using an algorithm developed from
a gold standard of ANC numbers captured from women’s ANC
cards during DSS round 27 (2012). The algorithm had a sensi-
tivity of 70% and positive predictive value of 98% for matching
ANC clinic records, with a similar algorithm used to match
CTC data (algorithms were based on a similar approach to
Kabudula et al).11 12 PMTCT register records were linked to
ANC and CTC records using ANC or CTC registration
numbers, respectively.
Sources of pregnancy data were child birth dates in the DSS
(linked to mothers), mothers’ self reports of pregnancies or
births in the DSS or serosurveys, and clinic pregnancy records.
Statistical analysis
Women residing in Kisesa in 2005–2012, testing HIV-positive
during any serosurvey, and pregnant during this interval were
eligible. HIV seroconversion dates were estimated using the
midpoint between ﬁrst positive and last negative test dates.
Prevalent cases were assumed to have seroconverted 3 years
prior to their ﬁrst positive test date (based on average duration
of infection for seroincident cases). The denominator comprised
HIV-positive pregnancies, excluding pregnancy records that
lacked serosurvey interview data within 5 years.
Two outcomes were assessed: (1) enrolled in a PMTCT pro-
gramme and/or CTC (‘HIV care’) during or before pregnancy,
and (2) accessed ARV drugs during pregnancy. Enrolment in
HIV care was deﬁned as linkage of a DSS record to a PMTCT
or CTC clinic record. Dates of clinic registration were aligned
with pregnancy dates to verify service access during each preg-
nancy. Maternal ARVaccess was deﬁned as receipt of ARV drugs
documented on any ANC visit in PMTCT registers, or a CTC
record indicating initiation or continuation of ART during
pregnancy (before the recorded or estimated delivery date).
Data on infant ARVs or HIV diagnoses could not be linked to
mothers’ records.
Explanatory variables were constructed using DSS data or ser-
osurvey questions, taking information from the round closest to
the pregnancy. Knowledge of HIV transmission was assessed by
asking respondents to mention any modes of HIV transmission.
ART knowledge was assessed using the number of correct
answers to ﬁve true or false statements about ART (detailed in
table 1). Responses to knowledge questions after the pregnancy
date were distinguished, as knowledge was hypothesised to
change as a result of attending the clinic. Death of a child was
deﬁned as any self-reported miscarriage, stillbirth or child death
after birth. VCTuse prior to pregnancy was based on attendance
at VCT in an earlier serosurvey, or self-reported VCTuse before
the pregnancy date. HIV status of partners was determined
using DSS line numbers of the spouse and spousal serosurvey
HIV test data. Age was modelled as a continuous variable; all
other quantitative variables were categorised.
Descriptive analyses, followed by bivariate and multivariate
logistic regression analyses (deemed appropriate given the short
and homogeneous follow-up time per pregnancy) were per-
formed using Stata V.12 (StataCorp LP, Texas, USA) to identify
independent predictors of access to HIV care or ARVs. All
factors associated with the outcome (p≤0.1) in bivariate ana-
lyses were assessed in multivariate models, using a forwards
stepwise approach. Variables were retained if they signiﬁcantly
improved the model ﬁt (p≤0.1, based on likelihood ratio tests).
Clustering due to multiple pregnancies per woman was
accounted for using random effects, checking for quadrature sta-
bility. Interactions with calendar year of pregnancy or age were
assessed. For continuous variables, departure from linearity was
assessed using likelihood ratio tests.
Ethical considerations
Informed consent was obtained from all serosurvey participants.
Data typists and managers received ethics training. Names of
patients with HIV were not visible to data typists. Data sets
were stored on password-restricted computer networks.
RESULTS
Participants
Among 9692 women of childbearing age residing in Kisesa in
2005–2012 who had ever attended a serosurvey, 848 (8.7%)
tested HIV-positive. Of these, 520 were pregnant between 2005
and 2012; 443 since (estimated) HIV seroconversion (n=810
pregnancies). Fifty-four pregnancy records lacking serosurvey
data within 5 years were excluded, yielding 756 pregnancies for
analysis (420 women) (see online supplement 2).
The pregnant women were 30 years old on average. Most
were married (70%), educated to primary level (73%), Christian
(94%) and from the Sukuma tribe (91%) (table 1). Half lived in
remote rural villages. Women primarily earned money through
farming (58%), and/or small businesses (28%). Few used VCT
prior to pregnancy (32%). In 2005–2006, 167 HIV-positive
women were pregnant; 209 in 2007–2008, 183 in 2009–2010
and 197 in 2011–2012.
Factors associated with enrolment in HIV care in Kisesa
Overall 180 HIV-positive women accessed HIV care (24% of
756 HIV-positive pregnancies); a range from 2% in 2005–2006
(n=3 out of 167) to 46% in 2011–2012 (n=90 out of 197)
(table 1). In crude analyses, access to HIV care increased with
increasing age (p<0.001, table 2). No women aged <20 years
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accessed care. Year of pregnancy was strongly associated with
accessing care, increasing sharply in 2009 (p<0.001).
Compared with women from rural villages, those from roadside
areas (OR 2.5 (95% CI 1.3 to 4.8)) or from the trading centre
(OR 1.6 (95% CI 0.8 to 3.2)) were more likely to enrol in care.
Unmarried women had lower odds of being in care than
married women (p=0.09). VCT prior to pregnancy (OR 6.7
(95% CI 3.5 to 13.0)), higher gravidity (p<0.001) and increas-
ing duration of HIV infection (p<0.001) were also associated
with receiving care. Women who named HIV transmission
modes (OR 5.3 (95% CI 1.2 to 24) for mother-to-child, OR 6.5
(95% CI 2.2 to 19) for other modes, vs none) and women who
correctly answered ≥four ART statements (OR 4.5 (95% CI 1.6
to 13) vs ≤two correct statements), were more likely to access
care. Having a relative with HIV (alive or dead) or knowing
someone taking ART was associated with higher odds of being
in care (OR 1.5 (95% CI 0.9 to 2.7) and OR 2.1 (95% CI 1.2
to 3.8) respectively). Women with HIV-positive or HIV-negative
partners appeared less likely to access care compared with the
larger group of women whose partners’ HIV status was
unknown (had not attended serosurveys) (p<0.001). There was
no statistical evidence for an association between enrolment in
care and educational level, religion, ethnicity, source of income
or death of a child. In multivariate analyses, increasing age,
increasing year of pregnancy, residence in roadside areas, being
married, increasing duration of infection and prior VCT were
independently associated with greater access to care (table 2).
Factors associated with accessing ARV drugs
Eighty-eight women accessed ARV prophylaxis or ART during
pregnancy (12% overall, 49% out of 180 in care). In bivariate
analyses, factors associated with ARVaccess mirrored those asso-
ciated with enrolment in care, except for area. Women whose
children had died appeared more likely to access ARVs (p=0.1).
Increasing age and year of pregnancy, being married, increasing
duration of infection and prior VCT remained independently
associated with improved ARVaccess in the ﬁnal models.
Factors over time
Patterns of access to care and ARVs by area or marital status
were similar over time (ﬁgure 2). Rural women were generally
disadvantaged, although the pattern was inverted in 2009–2010
for ARV usage. There was no statistical evidence for an inter-
action between year of pregnancy (or age) and area or other
variables (Gourlay11 includes further details of uptake and
coverage estimates over time).
Out of 50 women who had PMTCT in an earlier pregnancy,
42 (84%) accessed HIV care in their subsequent pregnancy.
Comparison of linked and non-linked clinic records
Kisesa-resident ANC records that were not linked to the DSS
(n=2579, 21%) did not differ in terms of age or year of ANC
registration (marital status not recorded at ANC) to the linked
ANC records (n=9842). However, compared to linked CTC
Figure 1 Cascade of prevention of mother-to-child transmission (PMTCT) services available in the dispensaries and/or health centre in Kisesa in
2009–2012, as well as referral services to city-based hospitals from 2005. ANC, antenatal clinic; PITC, provider-initiated testing and counselling;
ARV, antiretroviral; CTC, care and treatment clinic; VCT, voluntary counselling and testing. From 2005 to 2009, pregnant women diagnosed with HIV
at VCT services in the health centre were referred to hospitals in Mwanza city for PMTCT services. *In 2005–2011, HIV-positive pregnant women
with CD4 counts <200 cells/mm3 were eligible for antiretroviral treatment (ART) for their own health (lamivudine (3TC) or emtricitabine, plus
azidothymidine (AZT) or tenofovir, with efavirenz or nevirapine), otherwise ARV prophylaxis was provided: in 2005–2006 single-dose nevirapine at
onset of labour; in 2007–2011 AZT from 28 weeks gestation (single-dose nevirapine, AZT and 3TC during labour) until 7 days postpartum (AZT plus
3TC). The treatment threshold was raised to 350 cells/mm3 in 2012 (ARV prophylaxis from 14 weeks (drug regimens remained unchanged), ‘Option
A’).30 **In 2005–2006 infants received nevirapine within 72 h of birth; 2007–2011, infants received nevirapine for 1 week after birth and AZT for
up to 4 weeks. Under ‘Option A’ in 2012 they received nevirapine prophylaxis until 1 week after cessation of breastfeeding (4–6 weeks if
replacement feeding). Infant dried blood spot samples were sent for HIV testing to the national referral hospital in Mwanza city.
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Table 1 Characteristics of pregnancies (n=756) to HIV-positive women in Kisesa and proportions accessing HIV care/ARVs by factor
Factor Category
Total number (%)
of pregnancies
Number (%) in
‘HIV care’
Number (%)
accessed ARVs
Age <20 36 4.8 0 0.0 0 0.0
20–29 339 44.8 73 21.5 29 8.6
30–39 347 45.9 97 28.0 53 15.3
40+ 34 4.5 10 29.4 6 17.6
Year 2005–6 167 22.1 3 1.8 2 1.2
of pregnancy 2007–8 209 27.6 21 10.0 11 5.3
2009–10 183 24.2 66 36.1 23 12.6
2011–2012 197 26.1 90 45.7 52 26.4
Residence area Rural 371 49.1 70 18.9 44 11.9
Roadside 202 26.7 61 30.2 23 11.4
Trading Centre 183 24.2 49 26.8 21 11.5
Marital status Married now 529 70.0 138 26.1 67 12.7
Never married 69 9.1 10 14.5 3 4.3
Married before 158 20.9 32 20.3 18 11.4
Education At least P5 472 62.5 119 25.2 60 12.7
P1–4 80 10.6 13 16.3 8 10.0
No education 203 26.9 48 23.6 20 9.9
Religion Catholic 311 41.9 80 25.7 37 11.9
Other Christian 386 52.0 84 21.8 38 9.8
Muslim 21 2.8 7 33.3 5 23.8
Traditional 25 3.4 4 16.0 4 16.0
Ethnicity Sukuma 688 91.1 167 24.3 83 12.1
Other 67 8.9 13 19.4 5 7.5
(Personal) income Farming or manual work 438 58.2 102 23.3 51 11.6
Some business 208 27.6 48 23.1 28 13.5
None 107 14.2 30 28.0 9 8.4
Gravidity 1 86 11.4 10 11.6 4 4.7
(pregnancy number) 2 125 16.5 24 19.2 10 8.0
3 150 19.8 24 16.0 11 7.3
4 130 17.2 36 27.7 15 11.5
≥5 265 35.1 86 32.5 48 18.1
Any children died No 401 54.3 86 21.4 39 9.7
Yes 338 45.7 89 26.3 46 13.6
Duration of HIV ≤2 years 219 29.0 25 11.4 12 5.5
infection >2–4 years 209 27.6 39 18.7 12 5.7
>4 years 328 43.4 116 35.4 64 19.5
Prior VCT No 512 67.7 86 16.8 36 7.0
Yes 244 32.3 94 38.5 52 21.3
Knowledge of HIV None 96 12.7 11 11.5 6 6.3
transmission MTCT 35 4.6 12 34.3 6 17.1
Other modes 314 41.5 87 27.7 46 14.6
No prior report* 311 41.1 70 22.5 30 9.6
ART knowledge† ≤2 correct statements 119 15.7 36 30.3 17 14.3
3 correct statements 88 11.6 26 29.5 11 12.5
4–5 correct statements 87 11.5 42 48.3 26 29.9
No prior report* 462 61.1 76 16.5 34 7.4
Relatives with or No 493 66.7 107 21.7 47 9.5
died from HIV Yes 246 33.3 68 27.6 39 15.9
Know someone No 515 71.7 113 21.9 53 10.3
taking ART Yes 203 28.3 64 31.5 34 16.7
Partner HIV status Unknown‡ 450 59.5 135 30.0 66 14.7
Positive (had VCT) 10 1.3 0 0.0 0 0.0
Positive (no VCT) 34 4.5 4 11.8 3 8.8
Negative 50 6.6 3 6.0 3 6.0
No spousal link 212 28.0 38 17.9 16 7.5
Missing values: education (1); religion (13); ethnicity (1); income (3); children died (17); relatives died (17); know someone on ART (38).
*No prior report: knowledge data point after pregnancy, or from an earlier serosurvey questionnaire lacking the same question.
†Statements: “Drugs can only slow down HIV illness not stop it”; “ART drugs are very dangerous and can kill people”; “ART drugs have to be used for life”; “ART drugs are available
free of charge in Tanzania”; “Everyone who is infected with HIV needs drugs”.
‡Unknown to the study investigators.
ART, antiretroviral treatment; ARV, antiretroviral; MTCT, mother-to-child transmission; P1–4, primary level 1–4 years; P5, primary level 5 years; VCT, voluntary counselling and testing.
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Table 2 Crude and multivariate logistic regression models for factors associated with access to HIV care and ARVs during pregnancy (n=756 pregnancies)
Enrolled in HIV care Accessed ARV drugs
Factor Category OR 95% CI p (LRT) aOR 95% CI p (LRT) OR 95% CI p (LRT) aOR 95% CI p (LRT)
Age* 1.2 1.1 to 1.3 <0.001 1.1* 1.0 to 1.2 0.04 1.1 1.1 to 1.2 <0.001 1.1 1.0 to 1.2 0.05
Year of pregnancy 2005–2006 1 <0.001 1 <0.001 1 <0.001 1 <0.001
2007–2008 26.8 2.8 to 260 14 1.8 to 109 7.1 1.1 to 48 4.2 0.7 to 27
2009–2010 1753 75 to >5000 481 35 to >5000 415 5.1 to 325 21 3.0 to 142
2011–2012 7109 208 to >5000 1051 65 to >5000 207 21 to 2056 72 9.6 to 550
Residence area Rural 1 0.02 1 0.08 1 0.9
Roadside 2.5 1.3 to 4.8 3.4 1.0 to 11 1.0 0.5 to 2.0
Trading Centre 1.6 0.8 to 3.2 2.8 0.8 to 9.8 0.9 0.4 to 1.9
Marital status Married now 1 0.09 1 0.03 1 0.1 1 0.1
Never married 0.3 0.1 to 1.0 0.2 0.0 to 1.1 0.3 0.1 to 1.1 0.2 0.0 to 1.3
Married before 0.8 0.4 to 1.5 0.3 0.1 to 1.0 1.0 0.5 to 1.9 0.7 0.3 to 1.6
Education At least P5 1 0.2 1 0.7
P1–4 0.4 0.2 to 1.2 0.7 0.3 to 1.9
no education 1.0 0.6 to 1.9 0.8 0.4 to 1.5
Religion Catholic 1 0.6 1 0.4
Other Christian 0.8 0.4 to 1.4 0.8 0.5 to 1.5
Muslim 1.5 0.3 to 7.1 2.6 0.6 to 11
Traditional 0.5 0.1 to 2.6 1.6 0.4 to 6.5
Ethnicity Sukuma 1 0.7 1 0.7
Other 0.8 0.3 to 2.2 0.8 0.3 to 2.2
Personal income Farming/manual 1 0.7 1 0.6
income Some business 1.0 0.5 to 1.9 1.1 0.6 to 2.2
None 1.4 0.6 to 3.0 0.7 0.3 to 1.7
Gravidity (pregnancy number) 1 1 <0.001 1 <0.001
2 2.4 0.7 to 8.0 1.7 0.4 to 6.7
3 2.3 0.7 to 8.1 1.7 0.4 to 7.0
4 9.9 2.4 to 40 3.8 0.9 to 15
≥5 21.2 4.6 to 99 7.7 1.9 to 31
Any children died No 1 0.3 1 0.1
died Yes 1.4 0.8 to 2.3 1.6 0.9 to 2.8
Duration of HIV infection ≤2 years 1 <0.001 1 0.002 1 <0.001 1 0.002
>2–4 years 3.3 1.4 to 7.6 1.7 0.6 to 5.0 1.1 0.4 to 2.8 0.7 0.2 to 2.3
>4 years 20.7 6.9 to 61 7.4 2.1 to 25 6.4 2.7 to 15 3.7 1.2 to 11
Prior VCT No 1 <0.001 1 0.09 1 <0.001 1 0.02
Yes 6.7 3.5 to 13 2.2 0.9 to 5.8 5.4 2.8 to 11 2.5 1.1 to 5.8
Knowledge of HIV transmission None 1 <0.001 1 0.02
MTCT 5.3 1.2 to 24 5.8 1.2 to 29
Other modes 6.5 2.2 to 19 3.5 1.1 to 11
No prior report† 2.6 1.0 to 7.3 1.7 0.6 to 5.1
ART knowledge‡ ≤2 correct 1 <0.001 1 <0.001
3 correct 0.9 0.3 to 2.5 1.1 0.3 to 3.3
4–5 correct 4.5 1.6 to 13 5.3 1.8 to 16
No prior report† 0.2 0.1 to 0.4 0.4 0.2 to 0.9
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records (n=661), a greater proportion of non-linked CTC
records (n=174) were separated/widowed (19% vs 9%,
p=0.003), or were registrations prior to 2008 (25% vs 3%,
p<0.001) (data not shown), but there was no difference in age.
DISCUSSION
In this rural Tanzanian setting, access to PMTCT services was
low but increased over time, with fairly few though sometimes
strong inequities in service access. Area, marital status and age
predicted service use, alongside previously unexplored factors
including prior VCT and duration of HIV infection—ﬁndings
that could not have been deduced from a clinical cohort. Year of
pregnancy was, perhaps unsurprisingly, the strongest predictor
of access to care and ARVs, the large effect sizes reﬂecting the
availability of PMTCT services in Kisesa from 2009. The
increasing complexity and duration of PMTCT drug regimens
over time, as guidelines changed, did not appear to hinder
access to PMTCT care and ARVs, although it may have had an
impact on subsequent adherence which we were not able to
measure.
Pregnant women living in rural areas were less likely to enrol
in HIV care, with disparities persisting over time, likely reﬂect-
ing the greater distance, time and cost of travel to health ser-
vices; barriers that emerged in qualitative research on PMTCT
in this setting.13 Poorer uptake of VCT in remote villages in
Kisesa has also been documented.14 15 Further decentralisation
of CTC services to more rural areas, while maintaining regular
supplies of HIV test kits and drugs (a major issue during the
study, particularly in dispensaries),13 16 will be important in
ensuring all women in need of PMTCT services are reached.
Surprisingly, area of residence was not associated with uptake of
ARV drugs. This may be explained in part by the opposing pat-
terns of access to ARVs by area when disaggregated by time
period.
Unmarried HIV-positive pregnant women were less likely to
access care and acquire ARV drugs than married women, with
little change over time, potentially reﬂecting an absence of
support from male partners—an important determinant of
PMTCT service use in qualitative research in Kisesa and else-
where.4 17 In contrast, a few African studies found married or
cohabiting women were less likely to use PMTCTARVs or other
HIV services,14 18 19 perhaps due to perceived negative reactions
from partners. Support for HIV-positive women through NGOs,
community-based organisations (eg, Mothers2mothers)20 or
relatives may improve access.
Young pregnant women were particularly disadvantaged in
this setting, mirroring ﬁndings from several African studies.21–23
Qualitative research in Kisesa and South Africa suggests that
young HIV-positive pregnant women face discrimination in
health facilities.16 21 Providing additional support tailored to
young HIV-positive pregnant women and improving health
workers’ behaviour through training and supervision may
encourage attendance.
Increasing duration of HIV infection was a strong predictor
of access to HIV care in pregnancy, presumably reﬂecting devel-
opment of symptoms driving individuals to seek care. Shortages
of HIV-test kits and consequent prioritisation of testing and
enrolment for symptomatic women may also explain this
ﬁnding. Some women who accessed HIV care were already
attending the CTC before pregnancy, and may have been
referred from VCT services with symptoms. The association
between infection duration and ARV uptake also reﬂects ART
eligibility with increasing disease progression, although ineli-
gible women should have been offered prophylaxis. Qualitative
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research in East Africa suggests that asymptomatic HIV-positive
pregnant women feel ARVs for PMTCT are unnecessary,24–26
supporting our ﬁndings. Promoting VCT attendance, independ-
ently associated with access to HIV care and ARVs during preg-
nancy, may bring women into care and treatment earlier in their
infection. Implementation of Option B+ (lifelong ART for all
HIV-positive pregnant women) could also provide an incentive
for pregnant women to seek care and treatment earlier.27
Unlike studies of VCTuptake in Kisesa,14 28 we found no evi-
dence that HIV knowledge or education predicted PMTCT
service enrolment. However, our ﬁndings are consistent with
recent quantitative research on PMTCT service use.4
Contrasting ﬁndings between HIV services may reﬂect differ-
ences in service models and motivations for clinic attendance, in
which individuals seeking VCT actively decide to learn their
status, compared with pregnant women seeking routine ANC
services. Partner HIV status strongly predicted VCT uptake in
Kisesa, but was not independently associated with access to
PMTCT in this analysis. However, the small fraction of women
linked to partners with test results limited the statistical power
and conclusions we could draw.
The primary strength of this analysis was the linkage of com-
munity cohort and clinic data, enabling a population-level inves-
tigation of factors associated with PMTCT service use.
Nevertheless, we were unable to link some clinic records to the
DSS (adjusted coverage estimates are presented elsewhere29).
Unlinked clinic records did not differ in age, but were more
commonly separated/widowed women, potentially biasing our
estimates for marital status. Fewer clinic records from earlier
time periods were linked, so the association with year of
pregnancy may be overestimated, although this is unlikely to
have affected our conclusions. Selection bias is conceivable as
serosurvey attenders might be in worse health than non-
attenders (free treatment for non-HIV conditions is provided).
Estimated HIV seroconversion dates may be inaccurate,
although a sensitivity analysis limited to seroincident cases
revealed the same associations. The sample size limited the
power to investigate factors by time period, and was possibly
too small to detect smaller effects in multivariate analyses. We
were unable to investigate later PMTCT service outcomes, due
to data quality issues that hindered linkage of delivery or post-
partum records, or to examine ARV drug adherence. The true
beneﬁt of services may therefore be overestimated, although
factors associated with later outcomes would likely be similar. A
fraction of women may have accessed ANC outside Kisesa and
been misclassiﬁed as non-attenders (we were unable to collect
ANC records from clinics outside the area for cost and logistical
reasons). While the set of factors associated with service use will
vary by location, our ﬁndings may inform PMTCT programmes
elsewhere in Tanzania and rural Africa.
In conclusion, access to PMTCT services was low but
improved substantially over time, with a few strong sociodemo-
graphic differentials. Additional support for young or unmarried
women may be needed. Programmatic factors such as accessibil-
ity, HIV-test kit and drug availability, previous HIV service use
and patient-provider interactions may be strong drivers of
service use in this setting. Further decentralisation and strength-
ening of PMTCT services is necessary, while promoting VCT
and implementing Option B+ may bring women into care and
treatment sooner after HIV infection.
Figure 2 Proportion accessing HIV care by area or marital status, over time (top row); proportion accessing antiretrovirals (ARVs) during pregnancy
by area or marital status over time (bottom row).
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Key messages
▸ The majority of HIV-positive pregnant women did not access
available prevention of mother-to-child transmission (PMTCT)
services in this rural African setting.
▸ Limited service accessibility remains an issue for women
living in more remote areas, necessitating further
decentralisation of HIV and PMTCT services.
▸ Additional support is needed for young pregnant
HIV-positive women and those without partners.
▸ Promoting use of voluntary counselling and testing services
and implementing Option B+ may bring HIV-positive women
into care at an earlier stage of HIV infection.
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